Revenue
$774.63M
Fiscal year ended 2025-12-31Operating income
Unavailable
Fiscal year ended 2025-12-31Free cash flow
Unavailable
Fiscal year ended 2025-12-31Sabra Health Care REIT, Inc. (SBRA) reported revenue of $774.63M and net income of $155.61M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Sabra Health Care REIT, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Real Estate Investment Trusts.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $774.63M | $703.24M | $647.51M | $624.81M | $569.54M | $598.57M | $661.74M | $623.41M | $408.28M | $260.53M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Net income | $155.61M | $126.71M | $13.76M | -$77.60M | -$113.26M | $138.42M | $69.00M | $279.08M | $158.38M | $70.28M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 244.50M | shares 236.05M | shares 232.79M | shares 230.95M | shares 219.07M | shares 207.25M | shares 188.13M | shares 178.72M | shares 105.84M | shares 65.52M |
| Pretax income | $153.42M | $128.11M | $18.66M | $21.67M | $80.67M | $155.73M | $79.22M | $287.56M | $159.02M | $71.25M |
| Income tax expense | $1.84M | $1.00M | $2.00M | $1.24M | $1.84M | $710.00K | $3.40M | $3.01M | $651.00K | $1.05M |
| Diluted EPS | $0.64 | $0.54 | $0.06 | $-0.34 | $-0.52 | $0.67 | $0.37 | $1.51 | $1.40 | $0.92 |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $53.71M | $50.07M | $47.47M | $39.57M | $34.67M | $32.76M | $30.89M | $37.09M | $32.40M | $17.67M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $71.54M | $60.47M | $41.28M | $49.31M | $112.00M | $59.08M | $39.10M | $50.23M | $518.63M | $25.66M |
| Total assets | $5.49B | $5.30B | $5.39B | $5.75B | $5.97B | $5.99B | $6.07B | $6.67B | $7.03B | $2.27B |
| Current assets | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total liabilities | $2.67B | $2.56B | $2.58B | $2.69B | $2.59B | $2.58B | $2.58B | $3.41B | $3.60B | $1.25B |
| Current liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total equity incl. NCI | $2.82B | $2.74B | $2.80B | $3.06B | $3.38B | $3.41B | $3.49B | $3.25B | $3.44B | $1.02B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | $2.53B | $2.42B | $2.41B | $2.51B | $2.39B | $2.37B | $2.40B | $3.23B | $3.39B | $1.21B |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $348.61M | $310.54M | $300.57M | $315.73M | $356.39M | $354.85M | $372.48M | $360.59M | $135.79M | $175.93M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$377.96M | -$109.00M | $103.13M | -$216.25M | -$336.20M | -$136.45M | $262.84M | -$258.49M | -$182.56M | $142.36M |
| Financing cash flow | $40.76M | -$181.56M | -$410.30M | -$161.71M | $30.14M | -$202.11M | -$646.18M | -$629.34M | $598.82M | -$300.90M |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Stock-based compensation | $11.36M | $8.99M | $7.92M | $7.45M | $7.91M | $7.91M | $9.82M | $7.65M | $8.36M | $7.50M |
| Common dividends paid | $289.50M | $280.15M | $277.45M | $277.16M | $262.92M | $278.30M | $335.44M | $325.22M | $182.09M | $119.26M |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $187.00M | $169.62M | $183.09M | $187.78M | $178.99M | $176.74M | $181.55M | $191.38M | $113.88M | $68.47M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 1.5% | 1.3% | 1.2% | 1.2% | 1.4% | 1.3% | 1.5% | 1.2% | 2.0% | 2.9% |
| Current ratio | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Revenue YoY growth | 10.2% | 8.6% | 3.6% | 9.7% | -4.8% | -9.5% | 6.1% | 52.7% | 56.7% | Unavailable |
| Net margin | 20.1% | 18.0% | 2.1% | -12.4% | -19.9% | 23.1% | 10.4% | 44.8% | 38.8% | 27.0% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 1.2% | 0.8% | 10.7% | 5.7% | 2.3% | 0.5% | 4.3% | 1.0% | 0.4% | 1.5% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SBRA in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-03View SEC filing
10-Q · Filed 2026-04-29View SEC filing
10-K · Filed 2026-02-12View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-04View SEC filing
10-Q · Filed 2025-05-05View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.